- Home
- GNSS vs ANVS Comparison
GNSS vs ANVS Comparison
Compare GNSS & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNSS
- ANVS
- Stock Information
- Founded
- GNSS 1992
- ANVS 2008
- Country
- GNSS United States
- ANVS United States
- Employees
- GNSS N/A
- ANVS N/A
- Industry
- GNSS Consumer Electronics/Appliances
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- GNSS Consumer Staples
- ANVS Health Care
- Exchange
- GNSS Nasdaq
- ANVS Nasdaq
- Market Cap
- GNSS 98.9M
- ANVS 54.6M
- IPO Year
- GNSS N/A
- ANVS 2020
- Fundamental
- Price
- GNSS $1.74
- ANVS $2.33
- Analyst Decision
- GNSS Strong Buy
- ANVS Strong Buy
- Analyst Count
- GNSS 3
- ANVS 5
- Target Price
- GNSS $5.33
- ANVS $30.25
- AVG Volume (30 Days)
- GNSS 110.9K
- ANVS 612.2K
- Earning Date
- GNSS 08-05-2025
- ANVS 08-14-2025
- Dividend Yield
- GNSS N/A
- ANVS N/A
- EPS Growth
- GNSS N/A
- ANVS N/A
- EPS
- GNSS N/A
- ANVS N/A
- Revenue
- GNSS $27,780,000.00
- ANVS N/A
- Revenue This Year
- GNSS $91.14
- ANVS N/A
- Revenue Next Year
- GNSS $75.44
- ANVS N/A
- P/E Ratio
- GNSS N/A
- ANVS N/A
- Revenue Growth
- GNSS N/A
- ANVS N/A
- 52 Week Low
- GNSS $1.46
- ANVS $1.11
- 52 Week High
- GNSS $4.04
- ANVS $17.88
- Technical
- Relative Strength Index (RSI)
- GNSS 56.93
- ANVS 47.50
- Support Level
- GNSS $1.48
- ANVS $2.05
- Resistance Level
- GNSS $1.78
- ANVS $3.18
- Average True Range (ATR)
- GNSS 0.10
- ANVS 0.27
- MACD
- GNSS 0.04
- ANVS -0.11
- Stochastic Oscillator
- GNSS 90.63
- ANVS 24.34
About GNSS Genasys Inc.
Genasys Inc is a provider of Protective Communication solutions, including Genasys Protect software platform and Long Range Acoustic Device (LRAD). Its software platform receives information from variety of sensors and Internet-of-Things (IoT) inputs to collect real-time information on developing and active emergency situations. Genasys uses this information to create and disseminate alerts, warnings, notifications, and instructions through multiple channels before, during, and after public safety and enterprise threats, critical events, and other crisis situations. The Company operates in two business segments: Hardware and Software and its markets are North and South America, Europe, Middle East and Asia. Key revenue is generated from Hardware.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.